ACAD
31.22
-1.78
-5.39%
AEMD
5.1
-0.06
-1.1550%
APRI
0.475
-0.02
-4.0783%
ARNA
1.695
-0.015
-0.877%
ATEC
0.225
0.00
0.00%
CNAT
2.69
-0.03
-1.10%
CRXM
0.19
0.00
0.00%
CYTX
0.277
-0.023
-7.636%
DXCM
62.92
-2.18
-3.35%
GNMK
5.72
-0.12
-2.05%
HALO
10.377
-0.474
-4.3641%
ILMN
134.21
-1.71
-1.26%
INNV
0.091
+0.005
+5.814%
INO
10.62
-0.26
-2.39%
ISCO
3.72
0.00
0.00%
ISIS
57.56
0.00
0.00%
LGND
121.95
-1.07
-0.87%
LPTN
0.25
+0.035
+16.0465%
MBVX
0.635
-0.025
-3.788%
MEIP
1.45
+0.01
+0.69%
MNOV
6.86
-0.14
-2.00%
MRTX
21.05
-0.5
-2.32%
MSTX
0.31
+0.02
+6.8252%
NBIX
46
-0.71
-1.52%
NUVA
52.27
-0.34
-0.65%
ONCS
1.8
-0.08
-4.26%
ONVO
2.76
-0.07
-2.47%
OREX
0.468
+0.001
+0.2355%
OTIC
14.115
+0.155
+1.110%
QDEL
16.97
-0.21
-1.22%
RCPT
231.96
0.00
0.00%
RGLS
5.605
-0.325
-5.481%
RMD
55.825
-0.305
-0.543%
SPHS
1.35
+0.01
+0.75%
SRNE
6.96
-0.02
-0.29%
TROV
3.85
-0.14
-3.51%
VICL
0.376
-0.004
-1.0784%
VOLC
18
0.00
0.00%
ZGNX
10.5
+0.17
+1.65%
ACAD
31.22
-1.78
-5.39%
AEMD
5.1
-0.06
-1.1550%
APRI
0.475
-0.02
-4.0783%
ARNA
1.695
-0.015
-0.877%
ATEC
0.225
0.00
0.00%
CNAT
2.69
-0.03
-1.10%
CRXM
0.19
0.00
0.00%
CYTX
0.277
-0.023
-7.636%
DXCM
62.92
-2.18
-3.35%
GNMK
5.72
-0.12
-2.05%
HALO
10.377
-0.474
-4.3641%
ILMN
134.21
-1.71
-1.26%
INNV
0.091
+0.005
+5.814%
INO
10.62
-0.26
-2.39%
ISCO
3.72
0.00
0.00%
ISIS
57.56
0.00
0.00%
LGND
121.95
-1.07
-0.87%
LPTN
0.25
+0.035
+16.0465%
MBVX
0.635
-0.025
-3.788%
MEIP
1.45
+0.01
+0.69%
MNOV
6.86
-0.14
-2.00%
MRTX
21.05
-0.5
-2.32%
MSTX
0.31
+0.02
+6.8252%
NBIX
46
-0.71
-1.52%
NUVA
52.27
-0.34
-0.65%
ONCS
1.8
-0.08
-4.26%
ONVO
2.76
-0.07
-2.47%
OREX
0.468
+0.001
+0.2355%
OTIC
14.115
+0.155
+1.110%
QDEL
16.97
-0.21
-1.22%
RCPT
231.96
0.00
0.00%
RGLS
5.605
-0.325
-5.481%
RMD
55.825
-0.305
-0.543%
SPHS
1.35
+0.01
+0.75%
SRNE
6.96
-0.02
-0.29%
TROV
3.85
-0.14
-3.51%
VICL
0.376
-0.004
-1.0784%
VOLC
18
0.00
0.00%
ZGNX
10.5
+0.17
+1.65%
Home » Bio: Brian Orelli

Bio: Brian Orelli

Somewhere between his graduate thesis at the University of Chicago on BRCA1 and his postdoctoral fellowship in DNA repair at the Ludwig Institute, Brian realized he enjoyed analyzing other people’s data more than running his own experiments. And thus a career in science writing was born. Brian provides freelance articles for The Motley Fool, BioWorld, Nature Biotechnology, and anyone else that will let him write at the intersection of drugs and business.